Dysfunctional Immune-Privilege In Morbid Obesity: Implications and Effect of Gastric Bypass Surgery

被引:0
作者
D R Cottam
P A Schaefer
G W Shaftan
L D G Angus
机构
来源
Obesity Surgery | 2003年 / 13卷
关键词
MORBID OBESITY; CANCER; APOPTOSIS; CHRONIC INFLAMMATION; L-SELECTIN; FAS ANTIGEN; CD62L; CD95; LYMPHOCYTE; NEUTROPHIL; FLOW CYTOMETRY; IMMUNE PRIVILEGE; BARIATRIC SURGERY; GASTRIC BYPASS;
D O I
暂无
中图分类号
学科分类号
摘要
Background: Despite the epidemiological evidence linking obesity and cancer, there has never been a causal link.We believe the chronic inflammation present in obesity may predispose the obese to cancer through Fas-receptor over-expression and L-selectin under-expression in leukocytes, and elevated Fas ligand secretion in tumors affecting the morbidly obese. Methods: Leukocytes from 25 patients having gastric bypass surgery were compared to 15 normal controls preoperatively and at 1, 3, 6, and 12 months postoperatively using flow cytometry to measure CD3, CD4, CD8, CD56, CD62 (L-selectin), CD 69, and CD95 (Fas antigen) expression on T lymphocytes, B lymphocytes, natural killer cells, and neutrophils. Results: The percentage of CD95+T cells was significantly elevated from controls (69.4% vs 56%, P=0.005). This difference persisted through 1 month postoperatively. Furthermore, expression of CD95 per cell, was significantly greater in these patients than that of the controls (80.2 vs 62.6 gmf, P=0.018) preoperatively, and this continued to 1 month. Polymorphonuclear cells also displayed a similar elevation in CD95 gmf expression preoperatively (54.1 vs 40.7 gmf, P=0.023) which normalized by 3 months. Natural killer cells did not display elevated numbers of CD95 gmf preoperatively, but they did experience a significant decline by 12 months. Additionally, there was significant reduction in the number of naiveT cells [(T cells without L-selectin (CD62L)], when compared to normals preoperatively (41.8% vs 51.3%, P=0.001). There was no statistical difference between the postoperative patients and the controls by 3 months. CD69 was not different at baseline from controls in T or B cells, but there was a significant decrease by 12 months. Conclusion: The reduced expression of L-selectin combined with the elevated levels of CD95 suggests that morbid obesity predisposes patients to sites of immune privilege. This could be the mechanism for increased rates of cancer and wound infections seen in obesity. Surgically-induced weight loss eliminates these risk factors.
引用
收藏
页码:49 / 57
页数:8
相关论文
共 50 条
  • [41] Gastric bypass in a Japanese man with Prader-Willi syndrome and morbid obesity
    Kobayashi, J
    Kodama, M
    Yamazaki, K
    Morikawa, O
    Murano, S
    Kawamata, N
    Kawamura, I
    [J]. OBESITY SURGERY, 2003, 13 (05) : 803 - 805
  • [42] Laparoscopic mini-gastric bypass: an effective option for the treatment of morbid obesity
    Noun, R.
    Zeidan, S.
    [J]. JOURNAL DE CHIRURGIE, 2007, 144 (04): : 301 - 304
  • [43] Predictors of Inadequate Weight Loss After Laparoscopic Gastric Bypass for Morbid Obesity
    Al-Khyatt, Waleed
    Ryall, Rebecca
    Leeder, Paul
    Ahmed, Javed
    Awad, Sherif
    [J]. OBESITY SURGERY, 2017, 27 (06) : 1446 - 1452
  • [44] Predictors, treatment, and outcomes of gastrojejunostomy stricture after gastric bypass for morbid obesity
    Takata, Mark C.
    Ciovica, Ruxandra
    Cello, John P.
    Posselt, Andrew M.
    Rogers, Stanley J.
    Campos, Guilherme M.
    [J]. OBESITY SURGERY, 2007, 17 (07) : 878 - 884
  • [45] Effects of gastric bypass bariatric surgery on gut microbiota in patients with morbid obesity
    Amin, Urja
    Huang, Dora
    Dhir, Arun
    Shindler, Anya E.
    Franks, Ashley E.
    Thomas, Colleen J.
    [J]. GUT MICROBES, 2024, 16 (01)
  • [46] Gastric Bypass in a Japanese Man with Prader-Willi Syndrome and Morbid Obesity
    Junji Kobayashi
    Masaaki Kodama
    Kazuma Yamazaki
    Okamichi Morikawa
    Shunichi Murano
    Norifumi Kawamata
    Isao Kawamura
    [J]. Obesity Surgery, 2003, 13 : 803 - 805
  • [47] Laparoscopic gastric bypass in the treatment of morbid obesity -: Preliminary results of a new technique
    Luján, JA
    Hernandez, Q
    Frutos, MD
    Valero, G
    Cuenca, JR
    Parrilla, P
    [J]. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2002, 16 (12): : 1658 - 1662
  • [48] Effect of binge eating disorder on the outcomes of laparoscopic gastric bypass in the treatment of morbid obesity
    Garcia Diaz, Eduardo
    Jerez Arzola, Maria Elena
    Martin Folgueras, Tomas
    Morcillo Herrera, Luis
    Jimenez Sosa, Alejandro
    [J]. NUTRICION HOSPITALARIA, 2013, 28 (03) : 618 - 622
  • [49] Effect of weight loss after gastric bypass surgery on thyroid function in euthyroid people with morbid obesity
    MacCuish, A.
    Razvi, S.
    Syed, A. A.
    [J]. CLINICAL OBESITY, 2012, 2 (1-2) : 25 - 28
  • [50] Microbial flora of the stomach after gastric bypass for morbid obesity
    Ishida, Robson K.
    Faintuch, Joel
    Paula, Ana M. R.
    Risttori, Christiane A.
    Silva, Sabrina N.
    Gomes, Elaine S.
    Mattar, Rejane
    Kuga, Rogerio
    Ribeiro, Adriana S.
    Sakai, Paulo
    Barbeiro, Hermes V.
    Barbeiro, Denise F.
    Soriano, Francisco G.
    Cecconello, Ivan
    [J]. OBESITY SURGERY, 2007, 17 (06) : 752 - 758